A method that could lead to a safe and effective aerosol vaccine to prevent COVID-19 and to treat other respiratory infections has been identified by investigators at Rutgers Cancer Institute of New Jersey and Rutgers New Jersey Medical School. “Targeted pulmonary delivery is needle-free and minimally invasive, an attribute particularly relevant in the administration of multi-dose vaccines or other molecules. Also, because the lungs are constantly being exposed to pathogens from the air, they have a high level of immune defense activity, and therefore may represent an efficient site for complete immune protection against airborne pathogens,” said co-corresponding author Wadih Arap, director of Rutgers Cancer Institute of New Jersey at University Hospital and chief of the Division of Hematology/Oncology at Rutgers New Jersey Medical School. To read the full story.
Home / News / Rutgers Research Identifies Safe and Effective Method of Delivering Medicines to the Lungs
Recent Posts
- Could Hidden Infections Be Fueling Long COVID?
- Join NJ ACTS BERD on 1/22 for a Workshop with Dr. Yan Sun from NJIT
- How NJIT Graduate Student Jaimee Diogo Is Transforming STEM Futures Through ‘STEM Like a Girl’
- New Study Reveals Progress in Hospital Maternity Care Access in New Jersey, with Opportunities for Continued Improvement.
- Submit Your Proposal for Clinical Trials Days 2026
Categories
- Community (2,425)
- Covid (995)
- CTO Events (6)
- News (3,071)
- Pilots (21)